JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4251
Aehr Test Systems
AEHR
$3.5B
| $1.3M | ﹤0.01% |
64,355
+49,212
| +325% | +$1.19M |
2022 Q4
12 quarters
|
|
4252
ZIM Integrated Shipping Services
ZIM
$3.57B
| $1.3M | ﹤0.01% |
61,169
-108,462
| -64% | -$1.82M |
2021 Q1
19 quarters
|
|
4253
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.01B
| $1.29M | ﹤0.01% |
15,133
+782
| +5% | +$66.3K |
2021 Q2
18 quarters
|
|
|
DMII
4254
Drugs Made In America Acquisition II Corp
DMII
$649M
| $1.28M | ﹤0.01% |
+129,630
| New | +$1.28M |
2025 Q4
0 quarters
|
|
4255
Voyager Therapeutics
VYGR
$151M
| $1.28M | ﹤0.01% |
326,230
+108,819
| +50% | +$481K |
2017 Q3
33 quarters
|
|
|
HDUS
4256
Hartford Disciplined US Equity ETF
HDUS
$106M
| $1.28M | ﹤0.01% |
19,662
+1,282
| +7% | +$83.3K |
2023 Q3
9 quarters
|
|
4257
Granite Ridge Resources
GRNT
$590M
| $1.28M | ﹤0.01% |
272,073
+10,379
| +4% | +$53.6K |
2023 Q1
11 quarters
|
|
4258
Invesco Short Term Treasury ETF
TBLL
$2.63B
| $1.28M | ﹤0.01% |
12,077
+589
| +5% | +$62.3K |
2024 Q3
5 quarters
|
|
4259
German American Bancorp
GABC
$1.86B
| $1.28M | ﹤0.01% |
32,548
+70
| +0.2% | +$2.76K |
2013 Q2
50 quarters
|
|
4260
PUT
Matador Resources
MTDR
$6.62B
| $1.27M | ﹤0.01% |
30,000
| – | – |
2025 Q2
2 quarters
|
|
4261
Arbor Realty Trust
ABR
$664M
| $1.27M | ﹤0.01% |
163,612
+3,433
| +2% | +$33.6K |
2020 Q1
23 quarters
|
|
4262
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.29B
| $1.27M | ﹤0.01% |
10,039
-264
| -3% | -$33.1K |
2015 Q3
41 quarters
|
|
4263
Barings BDC
BBDC
$904M
| $1.27M | ﹤0.01% |
138,234
+911
| +0.7% | +$8.07K |
2023 Q4
8 quarters
|
|
4264
Cable One
CABO
$69.3M
| $1.27M | ﹤0.01% |
11,243
-2,572
| -19% | -$351K |
2015 Q3
41 quarters
|
|
4265
Flywire
FLYW
$2.14B
| $1.27M | ﹤0.01% |
89,504
+77
| +0.1% | +$1.05K |
2021 Q2
18 quarters
|
|
|
QHY
4266
WisdomTree U.S. High Yield Corporate Bond Fund
QHY
$239M
| $1.27M | ﹤0.01% |
27,270
-508
| -2% | -$23.6K |
2023 Q3
9 quarters
|
|
4267
PUT
Polaris
PII
$3.06B
| $1.26M | ﹤0.01% |
20,000
| – | – |
2024 Q2
6 quarters
|
|
4268
Arcturus Therapeutics
ARCT
$370M
| $1.26M | ﹤0.01% |
206,169
+2,562
| +1% | +$27.7K |
2019 Q2
26 quarters
|
|
|
DFSD
4269
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.27B
| $1.26M | ﹤0.01% |
26,288
+2,962
| +13% | +$143K |
2023 Q3
9 quarters
|
|
4270
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.12B
| $1.26M | ﹤0.01% |
15,308
+2,660
| +21% | +$215K |
2024 Q1
7 quarters
|
|
4271
Alerian MLP ETF
AMLP
$12.8B
| $1.26M | ﹤0.01% |
26,717
+17,435
| +188% | +$816K |
2013 Q2
50 quarters
|
|
4272
N-able
NABL
$799M
| $1.25M | ﹤0.01% |
167,572
-192,155
| -53% | -$1.47M |
2021 Q3
17 quarters
|
|
4273
CorMedix
CRMD
$560M
| $1.25M | ﹤0.01% |
107,768
+10,540
| +11% | +$117K |
2019 Q2
26 quarters
|
|
4274
Franklin US Low Volatility High Dividend Index ETF
LVHD
$591M
| $1.25M | ﹤0.01% |
31,391
+1,562
| +5% | +$63.3K |
2022 Q4
12 quarters
|
|
4275
CNA Financial
CNA
$12.5B
| $1.25M | ﹤0.01% |
26,188
+16,012
| +157% | +$738K |
2015 Q2
42 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.